AI Platform Streamlines Cancer Care at St. James’s Hospital, Dublin
A novel artificial intelligence (AI) tool is currently undergoing trials at St. James’s Hospital in Dublin, offering a possibly transformative approach to cancer patient care. Developed by Irish company eAltra, the AI-powered platform enables patients to remotely complete toxicity assessments and report symptoms directly from their smartphones.
The system is designed to proactively evaluate a patient’s suitability for treatment – particularly chemotherapy – before they travel to the hospital. this aims to minimize unnecessary journeys for patients who may ultimately be deemed ineligible for treatment on a given day, reducing both patient burden and strain on hospital resources.
According to reports, the conversational AI platform guides patients through a series of questions to assess their current health status and potential side effects. This information is then relayed to the oncology team, allowing for more informed decision-making and optimized treatment planning. The pilot program at St. James’s Hospital represents a notable step towards integrating AI into routine cancer care pathways in Ireland, potentially improving efficiency and enhancing the patient experience.
Keep reading